Calcitriol attenuates diethylnitrosamine-induced hepatic fibrosis in rats by reducing oxidative stress and fibrogenic mediators
PLOS One · 2026
DOI: 10.1371/journal.pone.0347908 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Komsan Arramrak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases, Department of Physiology, Faculty of Medicine…. Hauptthemen laut MEDLINE: Oxidative Stress, Diethylnitrosamine, Calcitriol, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Thailand Science Research and Innovation Fund, Chulalongkorn University, the Ratchadapiseksompotch Fund, Chulalongkorn University.
Abstract (Originalsprache)
Vitamin D deficiency is associated with poor outcomes and increased mortality in cirrhosis. Calcitriol, the active form of vitamin D 3 , has antioxidant and hepatoprotective properties; however, its effects on diethylnitrosamine (DEN)-induced liver fibrosis remain unclear. This study investigated the effects of calcitriol on oxidative stress, inflammation, and fibrogenesis in DEN-induced liver fibrosis rat model. Male Sprague-Dawley rats (n = 6/group) were assigned to four groups: control (CON), DEN, DEN + low-dose calcitriol (DEN + LVD 3 : 5 µg/kg BW), and DEN + high-dose calcitriol (DEN + HVD 3 : 10 µg/kg BW). Liver fibrosis was induced by weekly DEN injections (70 mg/kg, i.p.) for 8 weeks. Calcitriol was administered twice weekly (i.p.) throughout the experiment. Oxidative stress (hepatic malondialdehyde; MDA), liver injury (serum ALT, AST), hepatic inflammation (NF-κB p65), antioxidant gene expression (SOD-1, GPX-1), and fibrosis markers (TGF-β1, MMP-12, TIMP-1, α-SMA, collagen) were evaluated by biochemical assays, immunohistochemistry, qRT-PCR, western blotting and H&E and Sirius Red staining. Calcitriol significantly attenuated DEN-induced oxidative stress by decreasing hepatic MDA levels in a dose-dependent manner, and lowered serum ALT and AST levels. It partially enhanced hepatic antioxidant defenses by increasing SOD-1 expression toward control levels and upregulating GPX-1 expression. Calcitriol also markedly suppressed NF-κB p65 activation and fibrotic markers (TGF-β1, MMP-12, α-SMA, collagen), which corresponded with improved histopathological fibrosis scores. TIMP1 expression remained unchanged across all groups. Therefore, calcitriol attenuates DEN-induced liver fibrosis by reducing oxidative stress, suppressing inflammatory and fibrogenic signaling, and enhancing antioxidant defenses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of Excellence in Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Komsan Arramrak, Namthip Witayavanitkul
Förderung
- the Thailand Science Research and Innovation Fund, Chulalongkorn University
- the Ratchadapiseksompotch Fund, Chulalongkorn University
Zitieren
APA
Arramrak, K., Witayavanitkul, N., Chayanupatkul, M., Wanpiyarat, N., Siriviriyakul, P., & Werawatganon, D. (2026). Calcitriol attenuates diethylnitrosamine-induced hepatic fibrosis in rats by reducing oxidative stress and fibrogenic mediators. PLOS One. https://doi.org/10.1371/journal.pone.0347908
Vancouver
Arramrak K, Witayavanitkul N, Chayanupatkul M, Wanpiyarat N, Siriviriyakul P, Werawatganon D. Calcitriol attenuates diethylnitrosamine-induced hepatic fibrosis in rats by reducing oxidative stress and fibrogenic mediators. PLOS One. 2026. doi:10.1371/journal.pone.0347908
BibTeX
@article{Arramrak2026,
author = {Arramrak, Komsan and Witayavanitkul, Namthip and Chayanupatkul, Maneerat and Wanpiyarat, Natcha and Siriviriyakul, Prasong and Werawatganon, Duangporn},
title = {Calcitriol attenuates diethylnitrosamine-induced hepatic fibrosis in rats by reducing oxidative stress and fibrogenic mediators},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0347908}
}
EUVIMED